Eli Lilly & Co. (LLY) Reports In-Line Q4 EPS

Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $0.78, in-line with the analyst estimate of $0.78. Revenue for the quarter came in at $5.38 billion versus the consensus estimate of $5.32 billion.Eli Lilly & Co. reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Owlet (OWLT) Tops Q2 EPS by 9c
• Transact Technologies (TACT) Tops Q2 EPS by 1c